+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Hemodynamic Monitoring Systems Market 2019-2025

  • ID: 4863383
  • Report
  • October 2019
  • Region: Global
  • Orion Market Research Private Limited
UP TO OFF
until Mar 31st 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Endotronix, Inc.
  • Getinge AB
  • LiDCO Group PLC.
  • Retia Medical, LLC
  • Siemens AG
  • MORE
Global Hemodynamic Monitoring Systems Market Size, Share & Trends Analysis Report By Application (Invasive Monitoring Systems, Minimally Invasive Monitoring Systems, and Non-Invasive Monitoring Systems), By End-User (Hospitals and Clinics, Homecare, Ambulatory Surgery Centers), Forecast 2019-2025.

Hemodynamic monitoring systems are used in hospitals and other healthcare institutes for continuous monitoring of the blood movements and pressure exerted on the veins, chambers, and arteries of the heart. It is used to monitor a patient’s cardiovascular health, especially in the case of cardiac surgery. Major components of the hemodynamic monitoring systems include intravascular catheters, photometric systems, pressure transducing equipment, and electrical devices. These components along with invasive and non-invasive hemodynamic monitoring techniques ensure effective monitoring of the patient’s quality of life, cardiovascular health, and longevity.

Increasing prevalence of cardiovascular diseases and technological advancements in the hemodynamics monitoring systems are the major factors that are augmenting the growth of the market. Additionally, increasing geriatric population, growing need for critical congenital heart disease screening and increasing public-private partnership to minimize the healthcare cost are also one of the major factors that are driving the growth of the market. However, there are certain factors that are hindering the growth of the market. The risk associated with invasive monitoring systems is estimated to be the major constraint in the growth of the market.

The global hemodynamic monitoring systems market is segmented on the basis of application and end-user. On the basis of the applications, the market is segmented into invasive monitoring systems, minimally invasive monitoring systems and non-invasive monitoring systems. Further, on the basis of the end-user, the hemodynamic market is segmented into homecare, ambulatory surgery centers, and hospitals and clinics. The global hemodynamic monitoring systems industry is also segmented on the basis of the geographical region that includes North America, Europe, Asia-Pacific and Rest of the World. North America is estimated to account for major market share owing to the increasing prevalence of cardiovascular diseases in the region.

Further, Asia-Pacific is estimated to be the fastest-growing region during the forecast period due to increasing geriatric population and increasing government support and initiative to improve the quality of healthcare in the region. Rising incidences of cardiovascular diseases are also estimated to drive the growth of the market. Some of the prominent players of the hemodynamic monitoring systems market include General Electric, Co., Koninklijke Philips N.V., Getinge AB, Drägerwerk AG & Co. KGaA, FUJIFILM SonoSite, Inc., Edwards Life Science Corp., and ICU Medical, Inc. These key players are also focusing on expanding their offerings to regions through which the demand for the global hemodynamic monitoring systems market is flourishing.

Research Methodology

The market study of the global hemodynamic monitoring systems market is incorporated by extensive primary and secondary research . Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. the research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report is intended for hospitals, medical device manufacturers and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Hemodynamic Monitoring Systems Market Research and Analysis by Application
2. Global Hemodynamic Monitoring Systems Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the global hemodynamic monitoring systems market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global hemodynamic monitoring systems market.
  • Insights about market determinants which are stimulating the global hemodynamic monitoring systems market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Endotronix, Inc.
  • Getinge AB
  • LiDCO Group PLC.
  • Retia Medical, LLC
  • Siemens AG
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1 Getinge AB
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2 ICU Medical, Inc.
3.3.1.5. Overview
3.3.1.6. Financial Analysis
3.3.1.7. SWOT Analysis
3.3.1.8. Recent Developments
3.3.2. General Electric, Co.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Koninklijke Philips N.V.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Edwards Life Sciences Corp.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments

4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities

5. Market Segmentation
5.1. Global Hemodynamic Monitoring Systems Market by Application
5.1.1. Invasive Monitoring System
5.1.2. Minimally Invasive Monitoring Systems
5.1.3. Non-Invasive Monitoring Systems
5.2. Global Hemodynamic Monitoring Systems Market by End-User
5.2.1. Hospitals and Clinics
5.2.2. Homecare
5.2.3. Ambulatory Surgery Centers

6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Baxter International, Inc.
7.3. Deltex Medical Group PLC.
7.4. Drägerwerk AG & Co. KGaA
7.5. Edwards Life Sciences Corp.
7.6. Endotronix, Inc.
7.7. FUJIFILM SonoSite, Inc.
7.8. General Electric, Co.
7.9. Getinge AB
7.10. ICU Medical, Inc.
7.11. Koninklijke Philips N.V.
7.12. LiDCO Group PLC.
7.13. NI Medical, Ltd.
7.14. Osypka Medical, Inc.
7.15. Retia Medical, LLC
7.16. Schwarzer Cardiotek GmbH
7.17. Sensifree, Ltd.
7.18. Siemens AG
7.19. Teleflex, Inc.
7.20. USCOM, Ltd.
Note: Product cover images may vary from those shown
3 of 3
  • Abbott Laboratories, Inc.
  • Baxter International, Inc.
  • Deltex Medical Group PLC.
  • Drägerwerk AG & Co. KGaA
  • Edwards Life Sciences Corp.
  • Endotronix, Inc.
  • FUJIFILM SonoSite, Inc.
  • General Electric, Co.
  • Getinge AB
  • ICU Medical, Inc.
  • Koninklijke Philips N.V.
  • LiDCO Group PLC.
  • NI Medical, Ltd.
  • Osypka Medical, Inc.
  • Retia Medical, LLC
  • Schwarzer Cardiotek GmbH
  • Sensifree, Ltd.
  • Siemens AG
  • Teleflex, Inc.
  • USCOM, Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll